Biotech Values

[kris_kade]

India always been a double edged sword for big US pharmas. On one hand they want their patents to be protected but they continue to look into taping cheap resources even for highly skilled R&D not to speak of running clinical trials.

With no serious legal controls, US pharmas' outsourced R&D is one easy source for Indian generics companies to 'peek' thanks to resource attritions.